At first glance, the eye may seem far removed from the risks posed by microorganisms found in the environment. However, certain microscopic organisms can reach the cornea and cause severe inflammation that may threaten vision. One of the most notable conditions is Acanthamoeba keratitis, a relatively rare eye infection characterized by severe symptoms and diagnostic challenges. Delayed diagnosis can lead to serious and potentially permanent complications affecting the cornea.Acanthamoeba naturally exists in water, soil, and dust and can reach the eye under certain circumstances, particularly among contact lens wearers who expose their lenses to water or fail to follow proper hygiene and lens-care practices. The infection often begins with seemingly mild symptoms, such as eye redness, excessive tearing, and a sensation of having a foreign body in the eye. However, these symptoms may progress to severe eye pain, increased sensitivity to light, blurred vision, and damage to the corneal tissues.The danger of Acanthamoeba keratitis lies in the fact that its early symptoms can resemble those of other types of keratitis, making early diagnosis a significant challenge. In addition, some forms of Acanthamoeba are highly resistant to treatment, which can make the treatment journey lengthy and complex. In advanced cases, surgical intervention may be required to preserve the eye and help restore vision.Therefore, understanding this condition involves more than simply knowing its causes and symptoms. It also requires understanding its risk factors, modern diagnostic methods, medical treatment options, the role of surgery in severe cases, and the importance of prevention and proper contact lens care.In this Dalili Medical guide, we provide a comprehensive overview of Acanthamoeba keratitis, covering everything from the initial infection through diagnosis, treatment, and potential complications, with a particular focus on the importance of early detection before the condition causes permanent damage to the cornea or vision.
Acanthamoeba keratitis is a rare infection of the cornea caused by a free-living amoeba known as Acanthamoeba. The infection can be severe and may affect vision if it is not diagnosed and treated early.
Yes. Acanthamoeba keratitis can be serious, particularly when diagnosis is delayed or the infection does not respond adequately to treatment. In advanced cases, it may lead to corneal ulceration, thinning, or perforation and may leave a corneal scar that affects vision.
Acanthamoeba keratitis is not usually transmitted from person to person. The infection occurs when Acanthamoeba found in the environment, particularly in water or soil, reaches the cornea under conditions that allow the organism to cause infection.
Contact lens use is one of the most important risk factors for Acanthamoeba keratitis, particularly when lenses are not used or cared for properly. Risky practices include sleeping while wearing contact lenses, swimming or showering with them, rinsing them with tap water, or failing to disinfect and store them properly.
Yes. Acanthamoeba keratitis can occur in people who do not wear contact lenses, although this is less common. It may be associated with exposure of the eye to water or soil or with an injury or scratch to the surface of the cornea.
Yes. Exposure of the eyes to contaminated water during swimming may increase the risk of infection. The risk is particularly higher when contact lenses are worn while swimming.
Tap water may be a potential source of exposure to Acanthamoeba. Therefore, contact lens wearers are advised not to use tap water to clean their contact lenses or lens cases and not to rinse the lenses with tap water.
No. Severe eye pain can occur with many different corneal and eye conditions. Therefore, Acanthamoeba keratitis cannot be diagnosed based on pain alone.
You should not wait for spontaneous improvement if Acanthamoeba keratitis is suspected. The infection can progress and cause permanent corneal damage. Suspected cases therefore require prompt evaluation by an ophthalmologist.
Diagnosis is based on a combination of factors, including:
Diagnosis does not usually rely on a single test alone.
Yes. The symptoms and clinical findings can be similar during the early stages, which may result in delays in diagnosing Acanthamoeba keratitis. Coinfection with Acanthamoeba and other pathogens can also occur.
The risk of infection can be significantly reduced by following proper contact lens care practices. Important preventive measures include:
A large proportion of Acanthamoeba keratitis cases occur in contact lens wearers. This does not mean that wearing contact lenses itself causes the infection. Rather, the risk increases when contact lenses are used incorrectly or when proper hygiene and disinfection practices are not followed.
Some of the practices that may increase the risk of infection include:
Exposure of contact lenses to water is an important risk factor for Acanthamoeba keratitis because Acanthamoeba can be present in various water sources, including:
For this reason, it is recommended to avoid showering, swimming, or using hot tubs while wearing contact lenses.
The risk occurs because a contact lens may trap water and microorganisms close to the surface of the cornea, increasing the chance that Acanthamoeba can reach the eye. In addition, some types of soft contact lenses can absorb water, potentially changing their properties or causing them to adhere more closely to the corneal surface. This may lead to irritation or damage to the corneal surface and increase susceptibility to infection.
Any damage to the surface of the cornea can potentially provide an entry point for Acanthamoeba, even if the scratch is minor.
Corneal injuries may occur as a result of:
The risk may be higher when a corneal scratch or surface damage occurs together with exposure to water or an environmental source containing Acanthamoeba.
Contact lenses and their storage cases can become sources of microorganism buildup if they are not properly cleaned, disinfected, and maintained.
Common mistakes include:
Certain improper contact lens care practices have been associated with an increased risk of Acanthamoeba keratitis.
The use of certain types of lenses, including cosmetic contact lenses and orthokeratology (Ortho-K) lenses, may be associated with an increased risk of infection under certain circumstances, particularly when proper hygiene, disinfection, and usage instructions are not followed.
The risk may be further increased when these lenses are exposed to water, worn for extended periods, or stored improperly.
Acanthamoeba is a microorganism that is widely distributed in the environment and can be found in various places, including:
Eye pain is one of the most prominent symptoms of Acanthamoeba keratitis. The pain may be severe and deep and can persist continuously or occur in intermittent episodes.
Patients may describe the pain as:
Eye redness occurs as a result of inflammation and increased congestion of the blood vessels surrounding the cornea.
The redness may be:
Redness may become more pronounced as the inflammation and severity of the infection increase.
Sensitivity to light is a common symptom of Acanthamoeba keratitis. Patients may feel that normal levels of light have become uncomfortable or painful.
They may need to:
Sensitivity to light generally becomes more pronounced as corneal inflammation increases.
Inflammation of the cornea and irritation of the eye surface can stimulate excessive tear production.
Tearing may be:
Excessive tearing is a natural protective response as the eye attempts to protect the corneal surface from irritation and inflammation.
Patients may feel as though something is stuck inside the eye, even when there is no actual foreign object present.
This sensation may be described as:
As the inflammation progresses, the transparency of the cornea may be affected, leading to visual disturbances.
Patients may notice:
Patients may see circles or halos around light sources, particularly:
As inflammation progresses, the cornea may become swollen and lose some of its normal transparency.
During an eye examination, an ophthalmologist may observe:
Biguanides are among the most important topical medications used to treat Acanthamoeba keratitis. The main agents include polyhexamethylene biguanide (PHMB) and chlorhexidine.
PHMB is one of the main topical anti-Acanthamoeba medications and is included in a number of treatment protocols.
Commonly used concentrations include:
Treatment is usually started with a very intensive dosing regimen. Drops may be administered at frequent intervals during the initial phase and then gradually reduced as the cornea improves and inflammation becomes stable.
The prolonged duration of treatment is partly due to the need to control not only the trophozoite stage of Acanthamoeba but also its cysts, which are considerably more resistant to treatment.
Chlorhexidine is another important treatment option for Acanthamoeba keratitis and is used in some treatment protocols at a concentration of 0.02%.
A physician may use chlorhexidine instead of PHMB or, in certain situations, combine the two medications, particularly in severe or treatment-resistant cases.
However, combining topical medications may increase the risk of corneal surface toxicity. Therefore, the appropriate concentration, dosage, and frequency of administration should be determined under the supervision of a corneal specialist.
A physician may add a medication from the diamidines group to a biguanide, particularly in moderate or severe cases.
Important examples include:
Propamidine isethionate is used in some treatment protocols at a concentration of 0.1%.
Hexamidine 0.1% may be used as another option in certain cases and specialized centers.
A traditional treatment regimen may therefore involve:
PHMB or chlorhexidine + propamidine or hexamidine
The goal of combining these medications is to provide anti-Acanthamoeba activity through different pharmacological mechanisms.
However, there is no single treatment regimen that is appropriate for every patient. Some patients may respond well to treatment with a biguanide alone, whereas more severe cases may require combination therapy.
Treatment is generally very intensive during the initial phase, particularly when the diagnosis has been confirmed or there is a high level of suspicion for Acanthamoeba keratitis.
A corneal specialist may prescribe anti-Acanthamoeba eye drops at very frequent intervals during the first few days and then gradually reduce the frequency as signs of improvement appear.
The physician may assess treatment response based on several factors, including:
Surgical intervention may be considered when one or more of the following conditions are present:
Therapeutic surgery is primarily used in advanced or treatment-resistant cases. In general, elective visual rehabilitation surgery is preferably delayed until the infection has been controlled and the eye has become stable.
Therapeutic Epithelial Debridement / Corneal Debridement
Corneal debridement or removal of infected tissue may be used in selected cases. This procedure is not the same as a corneal transplant.
The ophthalmologist removes unhealthy superficial tissue from the cornea. This may include:
Anti-Acanthamoeba treatment is then continued intensively.
This procedure may help to:
However, debridement alone generally does not eliminate Acanthamoeba located within the corneal stroma. Therefore, it should not be considered a substitute for medical treatment.
Phototherapeutic Keratectomy (PTK) is a procedure that uses an excimer laser to remove selected superficial layers of the cornea.
It is not routinely used in all cases of Acanthamoeba keratitis. Instead, it may be considered in selected cases when the infection is relatively superficial, limited in depth, and has not responded adequately to medical treatment.
PTK may be appropriate when the infection is:
In general, the procedure involves:
The basic concept is to remove superficial infected or damaged tissue, which may also help improve the penetration of topical medications into the affected tissues.
If Acanthamoeba is present in the deep stroma, PTK is generally unlikely to be sufficient. Removing a large amount of stromal tissue may also result in dangerous corneal thinning.
Therefore, PTK is a selective treatment option rather than a routine treatment for all cases of Acanthamoeba keratitis.
Deep Anterior Lamellar Keratoplasty (DALK) is an important surgical option when the infection is confined to the anterior or mid-stroma while the deeper corneal layers remain healthy.
When the primary goal of the procedure is to remove active infection, it is referred to as:
Therapeutic Deep Anterior Lamellar Keratoplasty (TDALK)
In other cases, lamellar keratoplasty may be performed for visual rehabilitation after the infection has healed but a corneal scar or opacity remains and significantly affects vision.
The cornea consists primarily of several layers arranged from front to back:
Epithelium
↓
Bowman's layer
↓
Stroma
↓
Descemet's membrane
↓
Corneal endothelium
During DALK, the affected epithelium and infected stromal tissue are removed while attempting to preserve the deeper layers, particularly Descemet's membrane and the corneal endothelium.
DALK allows the surgeon to remove the affected portion of the cornea while preserving the patient's own corneal endothelium. This may reduce some of the risks associated with replacing the entire thickness of the cornea.
The exact surgical technique varies depending on the surgeon's approach and the condition of the cornea. However, the main stages can generally be summarized as follows:
The surgeon carefully evaluates the cornea using:
The goal is to determine whether the infection extends into deeper corneal layers that could make DALK unsuitable.
The damaged epithelium is removed, followed by gradual and carefully controlled removal of the infected stroma.
The surgeon attempts to reach a healthy deep corneal plane while preserving Descemet's membrane and the corneal endothelium whenever possible.
Suitable lamellar corneal tissue from a donor is prepared to match the portion removed from the patient's cornea.
The donor tissue is placed over the remaining deep corneal layer of the patient's eye.
The graft is secured using fine surgical sutures or another appropriate technique depending on the surgical method used.
Close postoperative monitoring continues after surgery. Anti-Acanthamoeba treatment may also be continued depending on the activity of the infection and the risk of recurrence.
It is important to emphasize that undergoing DALK does not automatically mean that anti-Acanthamoeba treatment can be discontinued.
DALK may not be suitable when the infection extends into the deeper layers of the cornea, such as:
In these situations, leaving the deeper layers in place may result in a risk of residual infection.
In such cases, the more appropriate option may be:
Therapeutic Penetrating Keratoplasty (TPK)
The depth of infection is one of the most important factors guiding the surgeon's choice between DALK and TPK.
Therapeutic Penetrating Keratoplasty (TPK) is one of the most important surgical procedures for advanced cases of Acanthamoeba keratitis.
It is a full-thickness corneal transplant primarily intended to remove infected corneal tissue, control the infection, and preserve the structural integrity of the eye.
TPK may be performed when there is:
At this stage, the primary goal is not immediate visual improvement but rather controlling the infection and preserving the eye.
The exact details vary depending on the individual case, but the main steps generally include:
The procedure may be performed under local or general anesthesia, depending on the patient's condition and the surgical team's assessment.
The surgeon identifies the ulcer, infiltrates, and unhealthy tissue and determines the appropriate size of the corneal area that needs to be removed.
A section of the cornea is removed through its full thickness. This is the key feature distinguishing TPK from DALK.
The surgeon aims to remove as much infected tissue as possible while avoiding unnecessary removal of healthy tissue.
A suitable donor corneal button is placed in the area from which the infected cornea was removed.
The graft is secured with fine surgical sutures. Depending on the case and surgical technique, interrupted or continuous sutures may be used.
The removed corneal tissue should be sent to the laboratory for evaluation for:
Close medical follow-up continues after surgery, and anti-Acanthamoeba treatment may be continued according to the corneal specialist's assessment.
Corneal Perforation
Corneal perforation is one of the most serious complications of Acanthamoeba keratitis. It may require urgent intervention to preserve the structural integrity of the eye and prevent loss of its contents.
The choice of procedure depends on:
Treatment options may include tissue adhesive, corneal patch grafting, or therapeutic keratoplasty.
Tissue adhesive may be used for certain small corneal perforations or areas of severe thinning that are at risk of perforation.
In general:
The adhesive does not eliminate Acanthamoeba. Its primary purposes are to:
Large perforations or perforations associated with deep infection may require therapeutic corneal transplantation.
Amniotic Membrane Transplantation (AMT) may be used in selected cases involving significant damage to the corneal surface or delayed epithelial healing.
It may be considered when there is:
The amniotic membrane may help to:
However, amniotic membrane transplantation is not a treatment for active Acanthamoeba infection and does not replace anti-Acanthamoeba therapy.
In some chronic or complicated cases, a portion of the conjunctiva may be used to cover the damaged area of the cornea.
A conjunctival flap may aim to:
However, there is an important limitation: covering the cornea may make it more difficult to monitor ongoing infection within the corneal tissue.
Therefore, a conjunctival flap is not a routine option for every case of Acanthamoeba keratitis and is reserved for selected cases determined by a corneal specialist.
Optical Penetrating Keratoplasty (Optical PKP) differs fundamentally from therapeutic corneal transplantation.
In TPK, the primary goal is to remove the infection and preserve the eye.
In Optical PKP, the infection has already been eliminated, but a visual problem remains because of a dense corneal scar or opacity.
A patient may progress through the following stages:
Acanthamoeba keratitis
↓
Anti-Acanthamoeba treatment
↓
Eradication of active infection
↓
Resolution and stabilization of the eye
↓
Persistent dense central corneal scar
↓
Continued visual impairment
In this situation, optical corneal transplantation may be considered to improve vision.
Optical keratoplasty is generally avoided while active infection is still present. Controlling the infection and ensuring that the eye has become stable are important factors for surgical success and for reducing the risk of recurrent infection or graft failure.
The surgical procedures used for Acanthamoeba keratitis can generally be divided into two main groups:
The primary goal is to remove infected tissue or protect the eye. These procedures may include:
The primary goal is to restore vision after the infection has been controlled. These procedures may include:
What's your complaint?